Cargando…

Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis

Neurofilament light (NFL) has proved to be a good prognostic factor in multiple sclerosis (MS), as its level is proportionally elevated with extended neuraxonal damage. The involvement of the kynurenine pathway in neuroinflammation has been proved. The precursor of this pathway is the essential amin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajda, Cecilia, Galla, Zsolt, Polyák, Helga, Maróti, Zoltán, Babarczy, Kristóf, Pukoli, Dániel, Vécsei, László
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216195/ https://www.ncbi.nlm.nih.gov/pubmed/32290514 http://dx.doi.org/10.3390/ijms21082665

Ejemplares similares

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
por: Pukoli, Dániel, et al.
Publicado: (2021)

Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System
por: Rajda, Cecilia, et al.
Publicado: (2015)

The Tryptophan-Kynurenine Metabolic System Is Suppressed in Cuprizone-Induced Model of Demyelination Simulating Progressive Multiple Sclerosis
por: Polyák, Helga, et al.
Publicado: (2023)

Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
por: Tanaka, Masaru, et al.
Publicado: (2021)

Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis
por: Rajda, Cecilia, et al.
Publicado: (2017)

Proteomic Analysis of Cerebrospinal Fluid in a Fulminant Case of Multiple Sclerosis
por: Füvesi, Judit, et al.
Publicado: (2012)

Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan–Kynurenine Metabolic System
por: Tanaka, Masaru, et al.
Publicado: (2022)

Kynurenine Pathway Metabolites in the Blood and Cerebrospinal Fluid Are Associated with Human Aging
por: Solvang, Stein-Erik H., et al.
Publicado: (2022)

Kynurenine Metabolites and Migraine: Experimental Studies and Therapeutic Perspectives
por: Fejes, Annamária, et al.
Publicado: (2011)

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease
por: Chatterjee, Pratishtha, et al.
Publicado: (2019)

Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia
por: Meeter, Lieke H H, et al.
Publicado: (2019)

Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease
por: Rodrigues, Filipe B., et al.
Publicado: (2021)

Elevated Neurofilament Light Chain in Cerebrospinal Fluid and Plasma Reflect Inflammatory MRI Activity in Neurosarcoidosis
por: Byg, Keld-Erik, et al.
Publicado: (2021)

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
por: Landqvist Waldö, Maria, et al.
Publicado: (2013)

Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies
por: Canaslan, Sezgi, et al.
Publicado: (2021)

Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia
por: Kessler, Christoph, et al.
Publicado: (2021)

A novel, robust method for quantification of multiple kynurenine pathway metabolites in the cerebrospinal fluid
por: Schwieler, Lilly, et al.
Publicado: (2020)

Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
por: Tanaka, Masaru, et al.
Publicado: (2020)

Cuprizone markedly decreases kynurenic acid levels in the rodent brain tissue and plasma
por: Polyák, Helga, et al.
Publicado: (2021)

Smouldering Lesion in MS: Microglia, Lymphocytes and Pathobiochemical Mechanisms
por: Pukoli, Dániel, et al.
Publicado: (2023)

A Case of HaNDL with Low Cerebrospinal Fluid Level of Neurofilament Light Chain
por: Sisman, Aysel Büsra, et al.
Publicado: (2020)

Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage
por: Meeker, Karin L., et al.
Publicado: (2022)

Neurofilament light chain levels in cerebrospinal fluid as a sensitive biomarker for cerebral adrenoleukodystrophy
por: Kakumoto, Toshiyuki, et al.
Publicado: (2023)

Exercise Diminishes Plasma Neurofilament Light Chain and Reroutes the Kynurenine Pathway in Multiple Sclerosis
por: Joisten, Niklas, et al.
Publicado: (2021)

A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer’s disease
por: Budelier, Melissa M., et al.
Publicado: (2022)

Editorial: The Impact of Neurofilament Light Chain (NFL) Quantification in Serum and Cerebrospinal Fluid in Neurodegenerative Diseases
por: Zanella, Isabella, et al.
Publicado: (2022)

Correction to “Neurofilament light chain levels in cerebrospinal fluid as a sensitive biomarker for cerebral adrenoleukodystrophy”
Publicado: (2023)

Kynurenines, neurodegeneration and Alzheimer’s disease
por: Kincses, Zsigmond Tamas, et al.
Publicado: (2010)

Cerebrospinal fluid neurofilament light chain predicts short-term prognosis in pediatric Guillain-Barré syndrome
por: Jin, Mei, et al.
Publicado: (2022)

Demographic and disease‐related factors impact on cerebrospinal fluid neurofilament light chain levels in multiple sclerosis
por: Zondra Revendova, Kamila, et al.
Publicado: (2022)

Cerebrospinal fluid level of neurofilament light chain is associated with increased disease activity in neuro-Behçet’s disease
por: KARAASLAN, Zerrin, et al.
Publicado: (2022)

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
por: Mattsson, Niklas, et al.
Publicado: (2016)

Cerebrospinal fluid and plasma neurofilament light relate to abnormal cognition
por: Osborn, Katie E., et al.
Publicado: (2019)

Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway
por: Boros, Fanni A., et al.
Publicado: (2019)

The Genetic Link between Parkinson's Disease and the Kynurenine Pathway Is Still Missing
por: Török, Nóra, et al.
Publicado: (2015)

Development of a translational inflammation panel for the quantification of cerebrospinal fluid Pterin, Tryptophan-Kynurenine and Nitric oxide pathway metabolites
por: Yan, Jingya, et al.
Publicado: (2022)

Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis
por: Le, Ngoc Dung, et al.
Publicado: (2020)

Association of Cerebrospinal Fluid Parameters and Neurofilament Light Chain With Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
por: Krajnc, Nik, et al.
Publicado: (2022)

Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
por: Bohár, Zsuzsanna, et al.
Publicado: (2015)

Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
por: Biernacki, Tamás, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6n9v97toj6u5gg94gbr2obdmhj